Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) in Subjects With Dim Light Vision Disturbances

Clinical trial NCT04638660 · COMPLETED

Trial details

NCT number: NCT04638660
Sponsor: Ocuphire Pharma, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Dim Light Vision Disturbances

Start date: 2020-12-30
Primary completion: 2022-05-19
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.